1. Home
  2. PAI vs RCEL Comparison

PAI vs RCEL Comparison

Compare PAI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Income Fund Inc.

PAI

Western Asset Investment Grade Income Fund Inc.

HOLD

Current Price

$12.39

Market Cap

118.3M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.50

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAI
RCEL
Founded
1973
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.3M
102.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PAI
RCEL
Price
$12.39
$3.50
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.75
AVG Volume (30 Days)
25.0K
205.1K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
4.78%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$72,401,000.00
Revenue This Year
N/A
$13.12
Revenue Next Year
N/A
$27.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.59
52 Week Low
$10.59
$3.25
52 Week High
$12.63
$14.16

Technical Indicators

Market Signals
Indicator
PAI
RCEL
Relative Strength Index (RSI) 49.18 43.10
Support Level $12.37 $3.25
Resistance Level $12.50 $3.58
Average True Range (ATR) 0.08 0.17
MACD 0.01 0.01
Stochastic Oscillator 44.89 44.00

Price Performance

Historical Comparison
PAI
RCEL

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: